Activity record

PGDB_A077257

Assay: % DegradationTarget: SALL4QC: standardized
Activity overview

degradation = 65 %

TargetSALL4
Cell lineKelly
Concentration100 nM
Time24 h
Assay / ReadoutWestern_blot / % Degradation
Assay IDPGDB_AS001684
PatentCN116457344A
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C019024
Compound IDPGDB_C019024
CompoundLenalidomide
Source record IDPGDB_C000057
InChIKeyGOTYRUGSSMKFNF-UHFFFAOYSA-N

Assay context

Assay IDPGDB_AS001684
Assay family% Degradation
Assay systemcell_based
Readout% Degradation
TechnologyWestern_blot
Concentration100 nM
Treatment time24 h
TargetSALL4
E3Not specified
Cell lineKelly

Source evidence

Patent IDCN116457344A
Compound location

Lenalidomide

Lenalidomide enlarged structureLenalidomide location on patent page 85
Activity table
Page 90 · table single